The bane of a silent illness: when Wilson's disease takes its course.
We present the case of a 21-year-old young lady with Wilson's disease, asymptomatic at first and consequently declining prophylaxis with chelating agents, who presented years after her diagnosis was made with multiple motor and neuropsychiatric manifestations of the disease, causing extensive morbidity and a major decrease in her quality of life. Following extensive education and supportive therapy, she showed conviction in the need for therapy. On close follow-up she continues to show compliance with appointments, the prescribed chelating agents, and psychotropic medication.
Chahine
Lama M
LM
American University of Beirut.
Chemali
Zeina N
ZN
D000328:Adult; D002614:Chelating Agents / Q000627:therapeutic use*; D015928:Cognitive Behavioral Therapy; D005260:Female; D006527:Hepatolenticular Degeneration / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D010349:Patient Compliance; D010353:Patient Education as Topic; D010879:Piperazines / Q000627:therapeutic use; D011788:Quality of Life; D013844:Thiazoles / Q000627:therapeutic use; D014266:Trientine / Q000627:therapeutic use; D015034:Zinc Oxide / Q000627:therapeutic use
D002614:Chelating Agents; D010879:Piperazines; D013844:Thiazoles; C092292:ziprasidone; D014266:Trientine; D015034:Zinc Oxide